Literature DB >> 20871219

P16/CDKN2A and Ki-67 enhance the detection of anal intraepithelial neoplasia and condyloma and correlate with human papillomavirus detection by polymerase chain reaction.

Edyta C Pirog1, Koen D Quint, Rhonda K Yantiss.   

Abstract

The classification of anal intraepithelial neoplasia (AIN) in mucosal biopsies is subject to considerable interobserver variability. Previous studies have shown that Ki-67 and p16/CDKN2A immunostains aid detection of dysplasia in biopsy samples from the uterine cervix. The aim of this study was to determine whether Ki-67 and p16/CDKN2A immunolabeling enhanced diagnostic accuracy in the assessment of anal mucosal biopsies from patients with suspected human papillomavirus (HPV) infection. The study consisted of 75 cases that were originally interpreted to represent normal anal transitional zone (n=15), fibroepithelial polyp (n=10), condyloma accuminatum (n=10), low-grade AIN (AIN1, n=20), and high-grade AIN (n=20), including 10 cases each of AIN2 and AIN3. The histologic features of all cases were re-reviewed and categorized based upon consensus agreement, which resulted in reclassification of 16 cases. Thus, the final study group consisted of 17 samples of normal anal transition zone, 14 fibroepithelial polyps, 6 condylomata accuminata, and 38 cases of AIN (11 AIN1, 16 AIN2, and 11 AIN3). Each case was tested for the presence of HPV DNA by a SPF10 polymerase chain reaction and LiPA25 genotyping assay and immunostained for Ki-67 and p16/CDKN2A. A positive Ki-67 result was defined as the presence of a cluster of at least 2 strongly stained epithelial nuclei in the upper two-thirds of the epithelial thickness. A positive result for p16/CDKN2A was defined as diffuse moderate-to-strong cytoplasmic and nuclear staining. None of the anal transition zone samples or fibroepithelial polyps showed Ki-67 or p16/CDKN2A staining. All condylomata and samples of AIN contained HPV DNA and showed positive Ki-67 labeling. All cases of high-grade AIN showed positive p16/CDKN2A staining. We conclude that Ki-67 labeling detects anal HPV-related changes with a high degree of sensitivity and specificity, whereas increased p16/CDKN2A staining is strongly associated with high-grade squamous neoplasia. These results indicate that a combination of these markers may aid interpretation of anal mucosal biopsy samples.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20871219     DOI: 10.1097/PAS.0b013e3181f0f52a

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  13 in total

1.  Proliferative index facilitates distinction between benign biliary lesions and intrahepatic cholangiocarcinoma.

Authors:  Christos G Tsokos; Gregor Krings; Funda Yilmaz; Linda D Ferrell; Ryan M Gill
Journal:  Hum Pathol       Date:  2016-07-07       Impact factor: 3.466

Review 2.  Screening, Surveillance, and Treatment of Anal Intraepithelial Neoplasia.

Authors:  Kevin C Long; Raman Menon; Amir Bastawrous; Richard Billingham
Journal:  Clin Colon Rectal Surg       Date:  2016-03

Review 3.  Pigmented anal squamous intraepithelial neoplasia: a case report and review of literature.

Authors:  Mitsuaki Ishida; Muneo Iwai; Akiko Kagotani
Journal:  Int J Clin Exp Pathol       Date:  2014-05-15

4.  Coexisting high-grade vulvar intraepithelial neoplasia (VIN) and condyloma acuminatum: independent lesions due to different HPV types occurring in immunocompromised patients.

Authors:  Kruti P Maniar; Brigitte M Ronnett; Russell Vang; Anna Yemelyanova
Journal:  Am J Surg Pathol       Date:  2013-01       Impact factor: 6.394

5.  Hybrid Capture 2 is as effective as PCR testing for high-risk human papillomavirus in head and neck cancers.

Authors:  Jody E Hooper; Jessica F Hebert; Amy Schilling; Neil D Gross; Joshua S Schindler; James P Lagowski; Molly Kulesz-Martin; Christopher L Corless; Terry K Morgan
Journal:  Appl Immunohistochem Mol Morphol       Date:  2015-04

6.  Characterization of topoisomerase II α and minichromosome maintenance protein 2 expression in anal carcinoma.

Authors:  Cristovam Scapulatempo-Neto; Carlos Veo; José Humberto T G Fregnani; Adriana Lorenzi; Allini Mafra; Armando G F Melani; Edgar Antonio Alemán Loaiza; Luciana Albina Reis Rosa; Cristina Mendes de Oliveira; José Eduardo Levi; Adhemar Longatto-Filho
Journal:  Oncol Lett       Date:  2017-01-25       Impact factor: 2.967

7.  p16 is superior to ProEx C in identifying high-grade squamous intraepithelial lesions (HSIL) of the anal canal.

Authors:  Rajeev Bala; Benjamin A Pinsky; Andrew H Beck; Christina S Kong; Mark L Welton; Teri A Longacre
Journal:  Am J Surg Pathol       Date:  2013-05       Impact factor: 6.394

8.  Biomarker P16 predicts progression risk of anal low-grade squamous intraepithelial lesions.

Authors:  Yuxin Liu; Morgan Blakely; Keith Sigel; Tin Htwe Thin; Pei Hui; Michael Donovan; Michael M Gaisa
Journal:  AIDS       Date:  2018-10-23       Impact factor: 4.177

9.  Laser capture microdissection as a tool to evaluate human papillomavirus genotyping and methylation as biomarkers of persistence and progression of anal lesions.

Authors:  Alyssa M Cornall; Jennifer M Roberts; Monica Molano; Dorothy A Machalek; Samuel Phillips; Richard J Hillman; Andrew E Grulich; Fengyi Jin; I Mary Poynten; David J Templeton; Suzanne M Garland; Sepehr N Tabrizi
Journal:  BMJ Open       Date:  2015-08-26       Impact factor: 2.692

10.  Use of human papillomavirus DNA, E6/E7 mRNA, and p16 immunocytochemistry to detect and predict anal high-grade squamous intraepithelial lesions in HIV-positive and HIV-negative men who have sex with men.

Authors:  Nittaya Phanuphak; Nipat Teeratakulpisarn; Somboon Keelawat; Tippawan Pankam; Jiranuwat Barisri; Surang Triratanachat; Amornrat Deesua; Piyanee Rodbamrung; Jiratchaya Wongsabut; Patou Tantbirojn; Saranya Numto; Preecha Ruangvejvorachai; Praphan Phanuphak; Joel M Palefsky; Jintanat Ananworanich; Stephen J Kerr
Journal:  PLoS One       Date:  2013-11-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.